Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
US7354606B2 · kind B2 · utility
1Cited by
15References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2005 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | Dec 7, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nutritional supplement composition contains inhibitors of alpha-glucosidase and alpha-amylase substantially in the absence of lipase inhibitors. The composition can include touchi extract and phaseolamin as the alpha-glucosidase and alpha-amylase inhibitor, respectively. A method of limiting the absorption of carbohydrates contained in a foodstuff includes administering the nutritional supplement composition prior to consumption of the carbohydrates, and a method promoting weight loss in an individual includes administering the nutritional supplement composition to the individual over a period of days.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.